Home Tools
Log in
Cart

Search Result

Search Results for " sst5 "

19

Compounds

Cat No. Product Name Synonyms Targets
TP2207 Pasireotide Acetate Somatostatin
Pasireotide Acetate is a stable cyclohexapeptide somatostatin mimic
T21944L BIM 23056 Acetate BIM 23056 Acetate (150155-61-6 Free base) Others
BIM 23056 Acetate is a  potent and surmountable human recombinant sst5 receptor antagonist.
TP1570L Cortistatin-14 acetate Cortistatin-14 acetate(186901-48-4 Free base) Somatostatin
Cortistatin-14 acetate, a neuropeptide have structural similarity to somatostatin-14, binds and exerts its function via the somatostatin receptors (sst1-sst5). Cortistatin-14 acetate shows anticonvulsive, neuroprotective...
TP1346 CYN 154806 TFA CYN 154806 TFA Somatostatin
CYN 154806 TFA is a cyclic octapeptide and an effective selective somatostatin sst2 receptor antagonist. For the recombinant sst2, sst1, sst3, sst4 and sst5 receptors, the pIC50 values are 8.58, 5.41, 6.07, 5.76 and 6.48...
T39262L BIM-23190 aceate Somatostatin
BIM-23190 aceate, a somatostatin analog, a selective agonist of SSTR2 and SSTR5. BIM-23190 can be used in cancer and acromegaly studies.
T22907 L-817,818 Others
somatostatin sst5 receptor agonist
T75844 BIM-23056 TFA
BIM 23056 TFA, a potent linear octapeptide antagonist of sst3 and sst5 somatostatin receptors, exhibits inhibition constants (K_i) of 10.8 for sst3 and 5.7 for sst5, according to reference [1].
TP2122 Seglitide
Peptide agonist for sst2 and sst5 somatostatin receptors. IC50/Kd values (nM) at cloned human somatostatin receptors are: > 1000 (sst1), 0.2 - 1.5 (sst2), 27 - 36 (sst3), > 127 (sst4), and 0.06 - 23 (sst5).
T76034 Cortistatin-14 TFA
Cortistatin-14 (TFA), a neuropeptide resembling somatostatin-14 in structure, operates through interaction with somatostatin receptors (sst1-sst5). This compound exhibits anticonvulsive and neuroprotective effects alongs...
T32511L L-796,778 acetate L-796,778 acetate(217480-25-6 Free base) Somatostatin
L-796,778 acetate is a slective somatostatin receptor agonist with IC50 of 24nM for sst3, for sst1, sst2, sst4 and sst5, IC50 is >1000nM.
TP1877 CYN 154806
CYN 154806 is a potent and selective somatostatin sst2 receptor antagonist, The pIC50 values are 8.58, 5.41, 6.07, 5.76 and 6.48 for human recombinant sst2, sst1, sst3, sst4 and sst5 receptors respectively.
TP2045 CH 275
Potent somatostatin receptor 1 (sst1) agonist; displays selectivity for sst1 (IC50 values are 30.9 nM, 345 nM, > 1 μM, > 10 μM and > 10μM for human sst1, sst3, sst4, sst2 and sst5 respectively). Attenuates somatostatin r...
T76596 PRL 3195
PRL 3195 is a somatostatin receptor antagonist, exhibiting K i values of 6, 17, 66, 1000, and 1000 nM for human somatostatin receptors sst 5 , sst 2 , sst 3 , sst 1 , and sst 4, respectively [1].
T11800 L-803087 Somatostatin
L-803087 is a potent and selective agonist of the growth inhibitor sst4 receptor with a Ki value of 0.7 nM for sst4, which is more than 280-fold more selective than other growth inhibitory receptors.L-803087 induced AMPA...
T76042 Angiopeptin TFA
Angiopeptin TFA, a cyclic octapeptide analogue of somatostatin, acts as a partial agonist at sst 2/sst 5 receptors, exhibiting IC50 values of 0.26 nM and 6.92 nM, respectively. This compound effectively inhibits the rele...
T25087 Angiopeptin D-Nal-cys-tyr-trp-lys-val-cys-thr-NH2,Bim 23014 C
Angiopeptin is a synthetic octapeptide analog of somatostatin; suppresses accelerated transplant atherosclerosis in rabbit heart arteries.
T13811 Pasireotide ditrifluoroacetate SOM230 ditrifluoroacetate,Pasireotide ditrifluoroacetate (396091-73-9 free base),Pasireotide TFA salt Others
Pasireotide is a stable cyclohexapeptide somatostatin mimic.
T12369 Pasireotide pamoate SOM230 pamoate Others
Pasireotide pamoate is a stable cyclohexapeptide somatostatin mimic. Pasireotide pamoate exhibits antisecretory, antiproliferative, and proapoptotic activity.
T39207 L-803087 TFA
L-803087 TFA is a highly potent and selective agonist of the somatostatin sst4 receptor, exhibiting a Ki value of 0.7 nM. It displays a remarkable selectivity, being over 280-fold more preferential for the sst4 receptor ...
TargetMol